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Conformational switching within dynamic
oligomers underpins toxic gain-of-function by
diabetes-associated amyloid
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Peptide mediated gain-of-toxic function is central to pathology in Alzheimer’s, Parkinson’s
and diabetes. In each system, self-assembly into oligomers is observed and can also result in
poration of artificial membranes. Structural requirements for poration and the relationship of
structure to cytotoxicity is unaddressed. Here we focus on islet amyloid polypeptide (IAPP)
mediated loss-of-insulin secreting cells in patients with diabetes. Newly developed methods
enable structure-function enquiry to focus on intracellular oligomers composed of hundreds
of IAPP. The key insights are that porating oligomers are internally dynamic, grow in discrete
steps and are not canonical amyloid. Moreover, two classes of poration occur; an IAPP-
specific ligand establishes that only one is cytotoxic. Toxic rescue occurs by stabilising non-
toxic poration without displacing IAPP from mitochondria. These insights illuminate cytotoxic
mechanism in diabetes and also provide a generalisable approach for enquiry applicable to
other partially ordered protein assemblies.
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Advancing molecular insight faces unique challenges whenstructure-function arises from partially ordered proteinoligomers1. Dynamic oligomers occur in aqueous and
membrane milieus, for example, giving rise to nucleoli2 and
signalling complexes3, respectively. As is often the case in biology,
functional examples are a product of selective pressure optimising
an intrinsic physical property of polypeptides. Unchecked, this
property can also result in the misassembly of normally mono-
disperse proteins. Gains-of-function from these states include
cytotoxicity while loss-of-function can occur as a result of irre-
versible fibre formation4.
Islet amyloid polypeptide (IAPP) is a 37-residue peptide-hor-
mone cosecreted with insulin by the β-cells of the pancreas. In
patients with type 2 diabetes, IAPP aggregation is associated with
loss-of-β-cell mass5. Orthologues and mutational studies reveal a
strong correlation between IAPP amyloid formation potential and
cytotoxicity. Nevertheless, it is the structurally poorly defined,
oligomeric species that are present prior to fibrillar aggregates
that appear cytotoxic. In solution, IAPP weakly samples α-helical
conformations that are stabilised upon interaction with phos-
pholipid bilayers6. Membrane catalysed self-assembly follows
binding with gains-of-function that include energy independent
membrane translocation, membrane poration and mitochondrial
localisation7. At the molecular level, the relationships of struc-
tures to functions, including downstream observations of mito-
chondrial dysfunction and cell death, remain unclear.
Membrane interacting oligomers whose structures and dynam-
ics result in poration are widely believed to underpin IAPP’s toxic
gain-of-function8. Membrane poration has also been reported for
Aβ from Alzheimer’s disease, α-Synuclein from Parkinson’s disease
and PrP from spongiform encephalopathy. These proteins also
contain disordered regions. Numerous studies using synthetic
vesicles have provided evidence for many alternative mechanisms:
discrete pore formation, membrane disruption through carpeting,
removal of phospholipid like a surfactant or as response to the
induction of surface tension9. Which, if any, of these mechanisms
is relevant inside cells is unknown. The role of molecular structure
in these phenomena is also unclear although there is indirect
evidence, such as the near loss-of-poration upon truncation of the
non-membrane bound and disordered C-terminal residues10.
Additionally, as IAPP localises to mitochondria, it is an appealing,
albeit unproven idea that IAPP uncouples mitochondria leading to
several downstream dysfunctions11. Clearly a deeper under-
standing of the molecular basis of IAPP-mediated poration and its
relationship to toxicity is required.
To address this challenge, we carried out parallel measure-
ments of IAPP on membrane models and inside live cells.
Synergy between cellular and model measurements was achieved,
in part, by engineering a permeation assay that uses a minimally
processed, cell derived membrane. Using this assay, two
sequentially sampled forms of poration are newly identified. A
previously developed IAPP-specific ligand, ADM-116, is used
here as a tool and shows toxic mitochondrial depolarisation to be
associated with only one of the two forms of poration. A
structure-based fluorescence approach, which we term diluted-
FRET, is developed that brings focus onto large, homooligomeric
assemblies of IAPP. We find that functional oligomers contain
scores to hundreds of IAPP, populate several discrete states and
none of these states are canonical amyloid. Our results support a
model whereby IAPP-mediated toxicity derives from large,
mitochondrial membrane associated assemblies of IAPP.
Results
IAPP mediates two classes of membrane permeation. IAPP
induces two kinetic phases of leakage in giant plasma membrane
vesicles (GPMVs). GPMVs were prepared from live INS-1 cells as
previously described12,13 with an additional step of pre-staining
cytoplasmic components with a thiol-reactive fluorescent probe,
CellTracker Orange (Fig. 1a). Upon addition of monomeric
(Supplementary Fig. 1) 50 μM IAPP to 5 μM GPMVs, a protein:
lipid (P:L) ratio of 10:1, two phases of leakage are observed
(Fig. 1b, d). This P:L is consistent with addition of low-μM
protein to cell culture which can result in P:Ls of 100:1 or more14.
Moreover, high-local concentrations of IAPP are expected in vivo
as IAPP is a secreted protein. The first phase of leakage
is exponential, k= 33 ± 2 s−1, ending at a plateau in which only
48 ± 4% of the starting intensity is lost. A second exponential
decay, k= 49 ± 2 s−1, begins after 1400 ± 200 s. This lag but not
the rates are strongly sensitive to protein concentration (Sup-
plementary Fig. 2a). The separation of two nearly identical rates
by a lag phase suggests that leakage is an indirect reporter of two
separate poration phenomena.
The two classes of IAPP-induced membrane permeation have
distinct sieve size. Fluorescence correlation spectroscopy (FCS)
was used to assess the diffusion of probes that escaped the lumen
of the GPMVs. In the absence of added IAPP, only background
counts are present. During the first kinetic phase, autocorrelation
analysis is possible and fits are readily made to an analytical form
that includes a single-diffusing species (Fig. 2a and inset). This
gives a diffusion constant of 390 ± 25 μm2/s which corresponds in
size to unconjugated dye. In marked contrast, data collection
during the second phase of leakage is characterised by large
irregular bursts that can persist for seconds and longer (Fig. 2a
and Supplementary Fig. 3). This reflects the presence of much
larger species (10–100 s of kDa)15. Clearly, the two phases of
leakage are characterised by a transition from one in which only
small and consistently sized holes are present to one in which
large heterogeneously sized species can escape.
Poration by IAPP is bidirectional. To measure influx, poration
was monitored by application of GFP (26 kDa) to a solution of
unlabelled GPMVs. The exclusion of GFP is readily observed and
stable (Fig. 2b). Application of 50 μM IAPP at 10:1 P:L shows
exclusion of GFP persisting for the first ~30 min. This is followed
by an abrupt change in which fluorescence within the lumen rises
to that of the surrounding buffer within ~80 min (Fig. 2c).
Exclusion during the first 30 min is consistent with large molecule
efflux also not occurring on this timescale (Fig. 2a). Small sieve
size poration is also bidirectional as evidenced using a small
molecule fluorescence quencher (Supplementary Fig. 2b). Clearly,
there is a discrete transition between small and large sieve size
poration regardless of whether this is observed using influx or
efflux assays.
Leakage resulting in large sieve size can be inhibited. ADM-116
is a recently developed16,17 small molecule inhibitor of IAPP-
induced cellular toxicity (Supplementary Fig. 7) (P= 0.0001).
ADM-116 has been shown to bind specifically to α-helical,
membrane-bound conformations of human IAPP. Moreover,
ADM-116 can cross the plasma membrane and has been shown
to directly bind intracellular IAPP. It is therefore uniquely suited
to making measurements on GPMVs that can be paired with
assessments performed inside live cells (see below).
IAPP assemblies associated with first- and second phase
leakage are structurally distinct. Leakage profiles were collected
on GPMVs with the addition of equimolar ADM-116 (Fig. 1c,d).
The resultant profile is exponential, k= 34 ± 1 s−1, with an
amplitude of 52 ± 3 %. This is within error of the first phase of
leakage observed in the absence of compound (Fig. 1d). FCS of
the media shows that only small solutes, with a diffusion
coefficient of 480 ± 50 μm2/s, have been released (Fig. 2a and
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Supplementary Fig. 3). In measurements using GFP as the
reporter, equimolar ADM-116 robustly inhibits influx into the
GPMV lumen (Fig. 2b, c). In summary, this ligand shows no
effect on small sieve-size leakage processes and wholly inhibits
formation of large sieve states. As ADM-116 binding to IAPP is
sequence and conformation specific16,17, this suggests that
structurally distinct assemblies mediate the two forms of observed
leakage.
ADM-116 is specific to pre-lag phase states of IAPP.
Experiments were performed in which ADM-116 was added at
early, middle and end stages of the lag phase (22, 32 and 42 min,
respectively). At 22 min, the results are indistinguishable from co-
addition of the compound at t= 0 (Fig. 1e). By 42 min, ADM-116
no longer affects the kinetics or sieve size of membrane poration.
Partial effects to kinetics and sieve size are apparent for additions
of compound at 32 min. These observations reinforce the
interpretation that the transition from one leakage phase to next
is a result of a structural change to membrane associated IAPP.
Poration occurs in transient bursts. Time resolved imaging was
performed using two probes: GFP and 50 μM IAPP doped with
200 nM IAPP labelled with Alexa 594. Striking, transient plumes
of GFP can be seen localised to IAPP puncta (Fig. 3a). Many time
points can be simultaneously considered by integrating intensity
along an axis from the center of the GPMV to the IAPP puncta
(Fig. 3b). In the first 20′, no GFP influx is observed. After 20′,
plumes are readily apparent and grow more regular in frequency.
Each GPMV has many IAPP puncta resulting in the observed
global increase in intensity over time (Fig. 3b). Similar mea-
surements monitoring efflux also shows unambiguous localisation
of leakage to IAPP puncta (Supplementary Fig. 4). Importantly,
when influx measures are performed in the presence of equimolar
ADM-116, IAPP puncta are present but plumes of GFP do not
occur (Fig. 3c). Previous work from our group suggested that
large membrane bound oligomers convert between open and
closed states in response to nucleation initiated by a subset of
IAPP within the oligomer18. We speculate that such nucleation
could form the basis of gating which in this assay, manifests as
transient plumes of GFP.
The sequential sampling of two forms of poration is a specific
property of IAPP. We determined that 10 μM of the mitochon-
drial protonophore, 2,4-dinitrophenol (DNP)19, can induce
CellTracker Orange efflux from GPMVs at a rate of 58 ± 8 s−1
(Fig. 1f). Intensity loss plateaus at ~50% with no large species
released (Supplementary Fig. 5) and material leaked has a
diffusion constant of 420 ± 24 μm2/s. These measures are within
error of the first kinetic phase observed using IAPP. Importantly,
there is no evidence of a second phase. In a contrasting study, a
sequence variant of IAPP was used. Rat IAPP (rIAPP) is
generally presented as non-toxic as cytotoxicity requires protein
concentrations that are significantly elevated compared to human
IAPP20. Here, 200 μM of rIAPP was empirically determined to
induce a first-phase leakage rate comparable to human IAPP
(Fig. 1f). The kinetic profile that follows is qualitatively similar in
that a plateau is present that is followed by a second phase of
leakage. Strong quantitative differences are present. This includes
a higher plateau, a lag phase of 10 s of hours and a second leakage
phase that does not go to baseline. Plainly, IAPP has the capacity
to induce two forms of leakage and the properties that govern
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Fig. 1 IAPP induces poration in a cell derived membrane. a–c Representative confocal images of CellTracker Orange labelled GPMVs at the indicated time
points. Shown are single GPMVs observed without added IAPP a, IAPP added to a ratio of 10:1 (IAPP:lipid), b and IAPP added in the presence of ADM-116
to a ratio of 10:1:10 (IAPP:lipid:ADM-116), c. d Integrated intensities across repeats of data as in a–c used to determine kinetic profiles of leakage from 5 μM
(phospholipid monomer units) GPMVs. e Leakage profile at 50 μM IAPP in the presence of equimolar ADM-116 added at the indicated delayed time points.
f Leakage profiles upon addition of 10 μM DNP or 200 μM of the sequence variant of IAPP from rats, rIAPP. Confidence intervals are standard deviations
from pairs of experiments conducted on three separate occasions, i.e., n= 6. Corresponding data for human "+IAPP only" in e and f are shown as an
overlay without confidence intervals. Scale bar for all images is 20 μm
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IAPP alters intracellular membrane integrity. IAPP localisation
to mitochondria is correlated with depolarisation. Mitochondrial
polarisation in live INS-1 cells was measured using the fluor-
ophore, JC-121 (Fig. 4a). Roughly 50% of intracellular IAPP was
localised to mitochondria (Fig. 4h). In contrast, only ~5% of
available IAPP overlaps with endoplasmic reticulum (ER) (Fig. 4h
and Supplementary Fig. 6) (P= 0.0003). At 13 μM IAPP, >50%
cell death is apparent after 48 h (Supplementary Fig. 7). This is
accompanied by widespread mitochondrial depolarisation
(Fig. 4b, e). Imaging at 24 h, a time point before cell death is
widespread, shows considerable depolarisation (Fig. 4e) relative to
the no IAPP control (P= 0.002). At this point, more than half of
the observable IAPP is localised to depolarised mitochondria
(Fig. 4f). That is in the lead up to cell death, mitochondria that
show co-localised IAPP also show depolarisation. Toxicity can be
reduced by conducting studies at reduced concentrations of IAPP.
At 5 μM IAPP, only ~15% of cells are dead after 48 h (Supple-
mentary Fig. 7). Imaging under this reduced toxic condition at 24
h shows the fraction of mitochondria with co-localised IAPP
(Fig. 4g) and depolarisation (Fig. 4e) are both greatly reduced (P
= 0.002 and 0.001, respectively). Plainly, localisation of IAPP to
mitochondria is associated with depolarisation and the extent of
depolarisation correlates with toxicity.
Cytotoxic rescue by ADM-116 eliminates mitochondrial
depolarisation without displacing IAPP. Small molecule rescue
was used as an orthogonal approach to reducing IAPP-induced
toxicity. Addition of equimolar ADM-116, 3 h after uptake of
13 μM IAPP wholly rescues INS-1 cells from toxicity16.
Depolarisation is markedly reduced compared to the 13 μM
IAPP-only images (Fig. 4d, e) (P= 0.0001). Importantly, ADM-
116 does not significantly change the fraction of IAPP co-
localised to mitochondria (Fig. 4h) (P= 0.48), nor the fraction of
mitochondria with associated IAPP (Fig. 4g) (P= 0.52). This
suggests that toxicity is reduced instead by changing the structure
of mitochondria associated IAPP. Our observation of mitochon-
drial depolarisation in response to IAPP may be direct or may be
upstream of stimulating other cellular factors. For example,
mitochondria initiated apoptosis includes membrane poration by
Bcl-2 family proteins22. Whether direct or indirect, changes in
mitochondria localised IAPP structure that we have associated
with changes in poration sieve size appear central to the origins of
toxicity.
Oligomers are dynamic during membrane leakage. Starting
with GPMVs and moving into cells, the above functional analyses
were paired with tools for assessing the gross morphology of
IAPP oligomers. Remarkably, fluorescently labelled IAPP puncta
on GPMVs show time dependent changes (Fig. 5a, b). Oligomer
growth dominates observation. Changes in oligomers that can be
interpreted as localised losses in size, fission and/or fusion are also
routine. These changes in IAPP oligomer morphology occur on
minute timescales, which is comparable to the observed IAPP-
induced leakage rates (Fig. 1). This suggests that IAPP dynamics
and poration are coupled.
Changes in dynamic oligomer morphology are also evident
using intermolecular FRET. IAPPs were prepared in which either
a donor (Alexa 488, IAPPA488) or acceptor (Atto 647, IAPPA647)
is covalently attached to the N-terminus. Unlabelled IAPP is then
mixed in high proportion (>50:1) with labelled peptides. This
orthogonal approach, which we term “diluted-FRET”, focuses
data collection on large oligomers. Oligomers, with a monomer
count (N) less than the dilution ratio, are statistically unlikely to
have both donor and acceptor present. As a non-dynamic control,
amyloid fibres of IAPP were prepared in aqueous buffer using
1:1:500 (donor:acceptor:unlabelled IAPP) and imaged using
confocal microscopy. A broad distribution of FRETeff is obtained
(Fig. 6a). When donor and acceptor fluorophores change their
orientations and/or positions on a timescale that is slow relative
to the integration time of measurement (here, 0.5 s per pixel),
then the expectation is that a broad distribution of FRET
efficiencies will be observed, reflecting the underlying spatial
distribution of donor–acceptor fluorophores23. This is observed
here for canonical amyloid fibres, where the peptide components
are not expected to have mobility. In marked contrast, the FRET
efficiency distributions observed for the oligomers are very
narrow (Fig. 6b); if the donor and acceptor peptides are rapidly
equilibrating through multiple conformations on the timescale of
the measurement, then narrow peaks corresponding to the
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Fig. 2 Alternative sieve sizes resulting from IAPP oligomer mediated
poration. a FCS of fluorescent conjugates that have leaked out of 5 μM
lumen labelled GPMVs after application of 50 μM IAPP. Representative
traces of photon bursts are monitored over time in the absence (magenta)
and presence of equimolar ADM-116 (black). Conditions are matched to
those used in Fig. 1b and c. Inset: two representative autocorrelation
analyses from the first 20min overlaid with fits (blue) to a single-diffusing
species. Autocorrelations were similarly computed for traces taken from 40
to 60min (Supplementary Fig. 3). b Confocal fluorescence imaging of 500
nM GFP in the presence of 5 μM unlabelled GPMVs. Leakage was initiated
by applying 50 μM IAPP. Conditions are matched to Fig. 1b, c. A
representative 0 and 3 h time point of the same GPMV is shown. On right is
a representative 3 h time point in which 50 μM ADM-116 was also present.
c Quantitation of kinetics of data as in b using summed intensities of GFP
across the equatorial plane of GPMVs. Confidence intervals are standard
deviations taken from a minimum of nine repeats. Scale bar for all images is
20 μm
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FRET observed here is intermolecular, the narrow peaks reflect
averaging from oligomer dynamics.
GPMV associated IAPP forms a discrete species when in
complex with ADM-116. Under conditions that display only
small sieve size poration (P:L:ADM-116= 10:1:10) (Fig. 1c, d),
FRETeff is readily measured from membrane associated puncta
using 1:1:500 (donor:acceptor:unlabelled IAPP) (Fig. 7a). Time
dependent changes to FRETeff show a progression of transitions
over ~40′ (Fig. 7c), i.e., structural transitions are occurring on the
same timescale as leakage. Signal averaging across repeats gives a
final profile of the stabilised state (Fig. 8a). The continued
presence of relatively narrow peaks suggests that the small
molecule stabilised species are still dynamic.
Two poration modes mediated by distinct non-amyloid states.
Under conditions for observing two phase leakage (P:L:ADM-
116= 10:1:0) (Fig. 8d), four peaks are apparent over the first 34′
with FRETeff at 0.21 ± 0.07, 0.36 ± 0.04, 0.41 ± 0.08 and
0.58 ± 0.02, respectively (Fig. 8e). The first three FRETeff peaks
dominate over a period of time in which only small molecule
leakage is observed. The second poration phase, 48′–60′, shows a
marked shift to two high-FRETeff ensembles at 0.78 ± 0.04 and
0.87 ± 0.01. The coincidence of the timescale of these transitions
with that observed for leakage (where all IAPP is unlabelled)
shows that fluorophore interactions are not contributing sig-
nificantly to the structures sampled by IAPP oligomers. This is
further confirmed by observation of comparable changes when
using an alternate donor/acceptor pair (Supplementary Fig. 8a).
None of these states yield FRETeff or histological staining24
similar to amyloid (Fig. 6a). Moreover, reducing the protein
concentration by half strongly lowers the sampling of second
phase leakage on the 48′–60′ timescale (Supplementary Fig. 2a).
The FRETeff over this time does not show significant sampling
near 0.78 and 0.87 (Fig. 8b) and indeed, more closely resembles
what is observed using ADM-116 ligand during this phase of
leakage (Figs. 7a, b and 8a). Clearly, membrane associated IAPP
oligomers are internally dynamic and are not dominated by
amyloid structures over the period of time where poration is
observed. Moreover, both time dependence and inhibitor studies
show different FRETeff species to be associated with the two
leakage processes.
IAPP oligomers grow by oligomer and not monomer addition.
Inspection of individual FRETeff time courses at 2′ resolution
shows peaks change in intensity, but not position (Fig. 7c, d).
That is new peaks appear as a result of others disappearing rather
than shifting. This is most further apparent in the time averaged
data (Fig. 8). The absence of significant peak broadening upon
averaging indicates that peaks do not shift in position over the
time course. That these changes likely represent oligomer growth
is evident in the approximately fivefold increase in intensity over
time (Fig. 8). These observations suggest that oligomer growth
does not occur by monomer or even small (N < ~10) oligomer
addition. Instead, the peaks correspond to distinct species the
sheer number of which (>6) make it unlikely that they represent
conformational transitions. Rather, we suggest that progression in
FRETeff includes contributions that are the result of a stepwise
merging of large-N oligomers.
Dynamic oligomers are responsible for cell toxicity. Intracel-
lular IAPP oligomers adopt a single-overall structure when
toxicity is rescued. INS-1 cells were incubated with 10 μM IAPP
and rescued from toxicity by addition of equimolar ADM-116 3 h
later (our standard condition16 to ensure intracellular interac-
tion). Intermolecular FRET is widespread indicating that large N
oligomers of IAPP are abundant (Fig. 9a). The FRETeff pixel
statistics show a single-narrow peak with FRETeff= 0.60 ± 0.07
(Fig. 9c). Over 48 h, this distribution does not significantly change
(Fig. 9c). A repeat analysis under at a different dilution of the
FRET pair, (1:1:500) (Fig. 9f), and analysis using a different FRET
pair, IAPPA488 and IAPPA594, give similar results (Supplementary
Fig. 9b, c), suggesting that fluorophore–fluorophore interactions
do not contribute significantly to the observation. The doping
ratio of 1:1:100 (donor:acceptor:unlabelled IAPP) that is pre-































Fig. 3 Poration occurs in discrete bursts at the site of IAPP oligomers. a Confocal fluorescence imaging of unlabelled GPMVs incubated in GFP containing
buffer. Data are collected under conditions matched to Fig. 2b with addition of 200 nM IAPP labelled with Alexa 594. Entry of GFP into the lumen of
GPMVs can be seen to occur as discrete bursts near IAPP oligomers (red). Four representative ROIs from independent GPMVs are shown. Note, for the
right two ROIs, IAPP is more abundantly present in an adjacent z-slice. Scale bar for is 20 μm. b, c Kinetic evaluation of plume formation near IAPP
oligomers. The intensity of GFP fluorescence along a radial line, (indicated schematically by an arrow that ends at an IAPP oligomer) was determined in the
absence (b) or presence (c) of equimolar ADM-116
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give data with the best dynamic range. This compares to 1:1:500
used for GPMVs. This suggests that the intracellular oligomers
are smaller than those observed on GPMVs. Importantly, a single,
long-lived discrete assembly of intracellular IAPP is formed upon
cytotoxic rescue by ADM-116; a result directly comparable with
that observed on GPMVs (Figs. 7a, c and 8a).
Intracellular oligomers of IAPP evolve to high-FRETeff under
conditions that are cytotoxic. Diluted-FRET was measured at 24 h
and 48 h as above, but without rescue using ADM-116 (Fig. 9b).
Cumulative analysis of cell images taken at 24 h reveal a broad
range of FRETeff= >0.5 (Fig. 9d). Individual cells (Fig. 9d), as well
as small sub-cellular ROIs (Fig. 9e) show recurring and relatively
narrow distributions. This is in line with observation of discrete
species observed on GPMVs (Figs. 7b, d and 8c). After 48 h, cells
show significant morphological signs of dysfunction. This is
accompanied by FRET distributions shifting to markedly higher
efficiencies (Fig. 9d, e). Plainly, the evolution of IAPP oligomer
conformations inside cells (and their inhibition with ADM-116)
mimic those sampled on GPMVs.
Intracellular oligomers of IAPP associated with cytotoxicity are
not canonical amyloid fibres. Diluted-FRET experiments were
repeated in cells using a doping ratio matched to that used for the
GPMV studies above, 1:1:500 (donor:acceptor:unlabelled IAPP).
In the absence of small molecule, the FRETeff progresses with
peaks at 0.36 ± 0.08 and 0.62 ± 0.04 at 24 h and 48 h, respectively
(Fig. 9g). The FRETeff distributions measured under these toxic
IAPP
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Fig. 4 Mitochondria co-localised IAPP is associated with depolarisation. a Representative INS-1 cells stained with JC-1 marker. Two fluorescence channels
in red and green correspond to polarised and depolarised mitochondria, respectively. These are shown and merged with the differential interference
contrast (DIC) image. A region of interest (ROI) is chosen to show channels individually. b Representative cells exposed to toxic (13 μM) concentrations of
IAPP doped with 200 nM IAPPA647 for imaging. Cells were stained with JC-1 marker 24 h after IAPP. The three channels, IAPPA647 (blue), polarised (red)
and depolarised (green) mitochrondria are shown merged with the DIC image. A ROI is chosen to show channels individually. c As in b but at 5 μM IAPP. d
As in b, but with the addition of 13 μM ADM-116 three hours after addition of IAPP (to ensure IAPP is intracellular16). e Image overlap statistics for a–d
showing ratio of depolarised/polarised mitochondria at the indicated conditions and incubation time. f Image overlap statistics for a–d showing fraction of
total IAPP overlapping depolarised mitochondria. g Image overlap statistics for a–d showing fraction of total mitochondria co-localised with IAPP. h Image
statistics showing fraction of total IAPP overlapping with mitochondria and ER. Representative images for these statistics are shown for mitochondria (b–d)
and ER (Supplementary Fig. 6), respectively. e–h For each measurement, a total of 50 cells from three biological replicates were selected for analysis. Error
bars are standard deviations. Statistical significance of the data was calculated (Student’s T-test). Comparisons made in the main text are indicated here
with lines and are annotated as ***P < 0.001 and ****P < 0.0001. P-values >0.01 are regarded as not significant (NS)
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conditions are clearly not the same as that of amyloid fibres
prepared in aqueous buffer (Figs. 9g and 10).
Discussion
The use of GPMVs as model system enabled the identification of
two forms of IAPP-mediated membrane permeation. This is
apparent from two kinetic phases in the leakage profiles (Fig. 1d)
each with a characteristic size distribution for the escaping
molecules (Fig. 2). Small molecule binding to IAPP inhibits the
second, but not the first, phase of leakage (Fig. 1d). A parallel can
be drawn between these results and the mitochondrial depolar-
isation measurements in cells (Fig. 4), where the small molecule
ligand reverses the depolarisation seen in the presence of IAPP,
without displacing IAPP from mitochondria. This observation is
significant, as it shows localisation of IAPP to mitochondria to be
necessary but not sufficient for toxicity. Instead, it appears that
the structure of IAPP at the mitochondria is a more relevant
indicator of toxic effect. We propose that nucleated conversion of
small pore permeable states to large pore permeation is the origin
of gains-in-toxic function by IAPP. This is an important dis-
tinction as membrane poration need not be cytotoxic.
The transition between small and large pore states reflects a
change in oligomer topology, and/or the conformation of IAPP
within the oligomer. This is suggested by the deviations of
observed FRETeff from simple models. For example, isotropic
packing of IAPP into a sphere at high density (4000 Å3/IAPP) can
be simulated. At the doping ratios used in GPMV experiments,
1:1:500, FRETeff cannot exceed ~0.27 (Fig. 6c). This is clearly
smaller than all but one of the observed peaks (Fig. 8c). Addi-
tionally, a ligand stabilising a membrane bound α-helical form of
IAPP affects only one of the two phases of poration (Fig. 1).
Taken together, these results support our assertion that there are
distinct membrane associated oligomeric states.
The evolution of the amyloid-hypothesis into the oligomer-
hypothesis was pioneered, in part, by the immunostained light-
microscopy observation of membrane associated puncta25. A
recent effort with bearing on our work is a study in which SDS
was used as a membrane model26. Toxic IAPP oligomers, chro-
matographically stable, discrete in size (~90 kDa), rich in α-helical
secondary structure, shown to enter cells and localise to mito-
chondria were reported. Remarkably, anti-sera from patients with
diabetes but not healthy controls were cross-reactive with this
oligomer. The 90 kDa size and subcellular localisation observed in
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Fig. 5 IAPP oligomers are dynamic. Confocal fluorescence imaging of 50 μM IAPP doped (500:1) with IAPPA594 and applied to 5 μM GPMV. Solution
conditions are matched to those used for FRET studies (Fig. 8). a A representative z-slice of a GPMV showing a region of interest (ROI) that contains an
oligomer. Imaging at 10′ intervals show evolution in oligomer structure. Green dashed lines indicate the location of the GPMV surface. b Three-dimensional
reconstruction of one oligomer from a narrow ROI near the equatorial plane and several neighbouring z-planes. The reconstructed image has been rotated
to show the oligomer from a perspective normal to the plane of the GPMV. Example of raw fluorescence is shown (left) followed by colour coded intensity





























b Simulated IAPP oligomerIAPP on GPMVIAPP amyloid in buffer















Fig. 6 Observed and expected behaviour for diluted FRET in oligomers of IAPP. a Canonical amyloid fibres were prepared by dilution of a stock solution of
IAPP into aqueous buffer. Stock solution contained a mixture of IAPPA488 (donor), IAPPA647 (acceptor) and unlabelled IAPP at 1:1:500. Confocal imaging
was used to prepare a FRETeff histogram (green). b Intermolecular FRET between IAPPA488 (donor) and IAPPA647 (acceptor) detected on GPMVs at the
indicated ratios of donor:acceptor:unlabelled protein. Each condition contains a protein equivalent of ADM-116 to maintain a stable conformation (Fig. 7a,
c). Each distribution represents the sum of observations taken from at least three different GPMVs. c Simulated average FRETeff for a dynamic, isotropic
spherical distribution of an oligomer composed of N copies of IAPP. Relevant simulation constants are volume per IAPP (4000 Å3), Förster distance (52 Å)
and the indicated ratio of (donor labelled IAPP):(acceptor labelled IAPP):(unlabelled IAPP)
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observations reported here. Our current study does not exclude a
significant role for dimer through hexamer formation as sug-
gested by others27–29. Instead, our work clarifies that oligomers
associated with gains-in-toxic function are much larger and
internally dynamic.
In functional systems, dynamic assemblies of membrane pro-
teins have been observed for Nephrin30 and more recently LAT3,
which forms micron sized clusters during T-cell activation. The
multistate nature of dynamic IAPP we report here is unlikely to
be unique. If functional membrane systems also leverage dis-
ordered regions to create alternative properties, their transitions
between states would likely be under regulatory control. We have
demonstrated here using IAPP that such transitions are suffi-
ciently defined as to be addressable with a protein-specific ligand.
The same may therefore be true for functional dynamic protein
phase transitions.
Methods
Materials. Chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless









































Fig. 7 Time dependent changes within membrane localised IAPP oligomers.
a, b Representative intermolecular FRETeff histograms between IAPPA488
and IAPPA647 in the presence of 50 μM unlabelled IAPP (1:1:500) in the
presence (a) and absence (b) of equimolar ADM-116. Confocal FRET
images are shown as a heat map merged with corresponding DIC images.
Ring shaped ROIs (green) are used to collect data that focus only on
membrane associated IAPP such as are shown as histograms in c, d. Scale
bar, 10 μm. c, d Data from single-optical sections of GPMVs monitored over
time after exposure to IAPP and ADM-116 at ratios of 10:1:10 (c) and 10:1:0
(d) protein:lipid:ADM-116. Images were recorded every 2min
IAPP + ADM-116, P:L = 10:1















































b IAPP only, P:L = 5:1
Fig. 8 Structural changes within IAPP oligomers occur on the same
timescale as poration. a Intermolecular FRET histograms at 10:1:10 IAPP:
lipid:ADM-116 summed over a minimum of three GPMVs, five optical
sections for each GPMV and the indicated periods of time. Conditions and
confocal fluorescence data collection are matched to those shown in Fig. 7.
b As in a but at 5:1:0 IAPP:lipid:ADM-116. c Diluted-FRET at 10:1:0 IAPP:
lipid:ADM-116. Pixel statistics correspond to summation across the
indicated time period. Red arrows indicate peaks used to define FRETeff
values for species referred to in the main text and the locations of dotted
red lines in b. Inset: Schematic of leakage profile collected under matched
conditions (Fig. 1d). Grey rectangles show the time period over which
FRETeff is summed in the associated histogram
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(Fair Lawn, NJ) and islet amyloid polypeptide (IAPP) from Elim Biopharmaceu-
ticals (Hayward, CA, USA). ADM-116 was previously prepared as described16.
IAPP stocks were prepared by solubilising ~2 mg protein in 7 M guanidinium
hydrochloride. The solution was filtered (0.2 micron) and transferred to C-18 spin
column, washed twice with water followed by a wash of 10% acetonitrile, 0.1%
formic acid (v/v) and then eluted into 200 µL of 50% acetonitrile, 0.1% formic acid
(v/v). The concentration of IAPP was determined by OD at 280 nm (ε= 1400M−1
cm−1). The solution was then divided into single use aliquots (20–50 µL), lyo-
philised, and stored at −80 °C. Stock solutions of IAPP were prepared with water
from these aliquots.
Alexa 488 carboxylic acid succinimidyl ester (A488), Atto 647 N succinimidyl
ester (A647) and Alexa 594 succinimidyl ester (A594) dyes were purchased from
Life Technologies (Carlsbad, CA). IAPP labelling was prepared as described
previously20. Briefly, IAPP was incubated with dye, succinimidyl ester on a
MacroSpin column for 4 h. Labelled IAPP was eluted from the MacroSpin column
with 50% acetonitrile/0.2% formic acid solution. This was then diluted with 7M
guanidinium hydrochloride solution to a total organic content of <5%. Labelled
protein was then purified by reverse-phase high-performance liquid
chromatography, and identity was confirmed by mass spectrometry. Aliquots were
lyophilised and stored at −80 °C. Stocks at 100 μM in water were prepared and
immediately before use. IAPP control fibres were prepared by incubating 50 μM
hIAPP and 100 nM IAPPA647 in 50 mM sodium phosphate buffer, 100 mM KCl,
pH 7.4, for ∼24 h. Fibres were pelleted at 21,000 g for 30 min and resuspended
three times using water.
GPMV. GPMVs were isolated from INS-1 cells as previously described13. Briefly,
cells were plated in 35 mm dishes and cultured for 48 h, washed with a 10 mM
HEPES, 150 mM NaCl, 2 mM CaCl2 (pH= 7.4) twice and then exposed to 2 mM
N-ethyl maleimide (NEM, Sigma Aldrich, St. Louis, MI, USA) for 2 h. Collected
samples were then passed over a gravity-flow column (Bio-Rad) containing size
exclusion Sephacryl of pore size 400-HR (Sigma Aldrich, St. Louis, MI, USA) to
separate GPMVs from residual cell debris. For leakage assays, the thiol-reactive
fluorescent probe, CellTracker Orange (Thermo Scientific, Rochester, NY, USA)
was first applied to cells at 1:1000 dilution and incubated for 1 h at 37 °C. The
phospholipid content of unlabelled and labelled final material was measured by
total phosphate assay. For leakage assays monitoring the influx of GFP, recombi-
nant expressed GFP (500 nM) was added to the GPMV containing solution and the
increase in fluorescence inside the GPMV was monitored.
GPMV imaging. Images were obtained in 8-well NUNC chambers (Thermo Sci-
entific, Rochester, NY, USA) containing 250 µl of GMPV at 5 μM phospholipid
lipid concentration. Imaging was carried out at the Yale Department of Molecular,
Cellular, and Developmental Biology imaging facility, on a Zeiss LSM 510 confocal
























































































Fig. 9 Intracellular oligomer conformations under toxic and rescued conditions are distinct. a, b Intermolecular diluted FRET between IAPPA488 and
IAPPA647 (in the presence of unlabelled IAPP, 1:1:100) imaged in live INS-1 cells under rescued (a) and toxic (b) conditions. Pixel-based FRET analysis of
representative cells is shown as a heat map merged with corresponding DIC images. Scale bar, 10 μm. c–g Histograms of pixel counts for FRETeff images as
in a and b. c FRETeff histograms for cells at 24 h (black) and 48 h (cyan) for the ADM-116 rescued condition (a). Analysis for a representative single cell is
shown above the sum of data collected from 50 cells from three independently conducted experiments on each of three different days. d Analysis as in c,
but under conditions of ~50% toxicity (10 μM IAPP). e Analysis as in d, but for representative ROIs within single cells. f, g Effect of FRET dilution on
experiments matched to b and c except that IAPPA488 and IAPPA647 are instead diluted 1:1:500 with 10 μM unlabelled IAPP. Sums of data collected from 50
cells are shown. g Intracellular FRET observed under toxic conditions are not amyloid. Diluted-FRET of the toxic condition, 10 μM IAPP, measured inside
cells after 48 h (cyan). These are overlaid with FRETeff statistics of a control in which IAPP is in an amyloid conformation at 1:1:500 (green, Fig. 6a)
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capability (Carl Zeiss, Oberkochen, Germany). Image acquisition and processing
were achieved using Zeiss Efficient Navigation (ZEN) and Image J software31.
Fluorescence correlation spectroscopy (FCS). FCS measurements were made on
an LSM 880 Airyscan system NLO/FCS Confocal microscope (Carl Zeiss, Ober-
kochen, Germany) with a C-Apochromat ×40/1.2 NA UV-VIS-IR Korr. water
immersion objective (Carl Zeiss, Oberkochen, Germany). Thiol-conjugated mole-
cules were excited at 594 nm. Confocal pinhole diameter was adjusted to 70 μm.
Emission signals were detected through a 607-nm long-pass filter. Measurements
were made in 8-well chambered coverglasses (Nunc, Rochester, NY, USA). All
samples were incubated in GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM
CaCl2 (pH= 7.4)) for 1 h prior to taking measurements. Autocorrelation data were
collected at regular intervals (5 min) with each autocorrelation curve collected over
10 s with 30 repeats.
Autocorrelations were fit using the software QuickFit3.032. For thiol-conjugates,










here, N is the total thiol-conjugated molecules in the detection volume. The
characteristic translational diffusion time of a diffusing particle is given by τd,1. The
structure factor, s, was determined as a free parameter for solutions of free Alexa
594 hydrazide dye and then fixed to the experimentally determined value of 0.1 for
all subsequent fittings. For experiments of conjugates eluting during the second
decay phase of leakage diffusion was assessed by burst counts within the time frame
analysed.
Confocal microscopy and cell imaging. Images were obtained in 8-well NUNC
chambers (Thermo Scientific, Rochester, NY, USA) seeded with 20000–25000 cells/
well. Cells were cultured for 48 h after passage before beginning experiments. For
time dependent co-localisation experiments of IAPP with JC-1 mitochondrial
staining, the medium contained 200 nM IAPPA647, 13 µM unlabelled peptide. For
experiments in the presence of ADM-116, 13 µM of molecule was introduced in the
medium following a 3 h incubation of cells with IAPP. For experiments monitoring
mitochondria, JC-1 was incubated with cells at 1:5000, at 37 °C for 45 min prior to
addition of protein. Images were acquired after 48 h total incubation time. Imaging
was carried out using a ×100 Plan-Apo/1.4-NA oil-immersion objective with DIC
capability (Carl Zeiss, Oberkochen, Germany). For all experiments reporting on the
co-localisation of labelled IAPP, the gain setting for the blue channel was kept
constant from sample to sample. Mitochondria containing JC-1 aggregates were
detected in red (excitation 540 nm, emission 570 nm), and monomers in the green
channel (excitation 490 nm, emission 520 nm). Image acquisition and processing
were achieved using Zeiss Efficient Navigation (ZEN) and Image J software31.
Intracellular imaging Förster resonance energy transfer. The INS-1 growth
media was replaced with media containing 100 nM IAPPA488 and 100 nM
IAPPA647 (or 100 nM IAPPA594) and unlabelled IAPP and incubated for the
timescales indicated in the text. Media were replaced with fresh prior to imaging. In
experiments where ADM-116 was used, small molecule was added 3 h after
incubation with protein. Images were acquired using a ×100 Plan-Apo/1.4-NA oil-
immersion objective with DIC capability (Carl Zeiss, Oberkochen, Germany). For
the donor channel, IAPPA488 was excited with a 488 nm Argon2 laser and detected
through a 505/550 nm emission filter. For the acceptor channel, IAPPA647 was
excited with a 633 Argon2 laser and detected through a 730/750-nm emission filter.
For all experiments the pinhole was kept constant to the Z-slice thickness of each
filter channel. Single-cell images were obtained for donor alone, acceptor alone and
donor–acceptor fusion channels. Image acquisition and processing were achieved
using Zeiss Efficient Navigation (ZEN) and Image J software33. The Image J plugin,
RiFRET34, was used to calculate and remove the bleed through for each channel







where E is the calculated efficiency of FRET energy transfer, R0 is the Förster
distance and r is the distance between the donor and the acceptor.
Imaging FRET. GPMV experiments were conducted in 8-well NUNC chambers
(Thermo Scientific, Rochester, NY, USA) including 250 µl of GMPV stock solution
at 5 μM apparent phospholipid (in monomer units). Wells containing GPMVs
were mixed with 100 nM IAPPA488 and 100 nM IAPPA647 (or 100 nM IAPPA594)
and unlabelled IAPP. In experiments where ADM-116 was used, small molecule
was added at the same time as protein. The same microscope setup and analysis
procedure was used to image FRET in GPMVs and cells.
Cell culture. Rat insulinoma INS-1 cells (832/13, Dr. Gary W. Cline, Department
of Internal Medicine, Yale University) were cultured at 37 °C and 5% CO2 in
phenol red free RPMI 1640 media supplemented with 10% fetal bovine serum, 1%
penicillin/streptomycin (Life Technologies, Carlsbad, CA, USA), and 2% INS-1
stock solution (500 mM HEPES, 100 mM L-glutamine, 100 mM sodium pyruvate
and 2.5 mM β-mercaptoethanol). Cells were passaged upon reaching ~95% con-
fluence (0.25% Trypsin-EDTA, Life Technologies), propagated, and/or used in
experiments. Cells used in experiments were pelleted and resuspended in fresh
media with no Trypsin-EDTA. We follow ATCC guidelines for authentication of
non-human cell-lines (technical bulletin #8, http://atcc.org). This includes mon-
itoring mycoplasma, morphology and growth rate. We regularly thaw fresh stocks
and begin and track new sequences of passages. We do not perform species
verification.
Cell viability. Cell viability was measured colourimetrically using the Cell-Titer
Blue (CTB, Promega, Madison, WI, USA) fluorescence-based assay. Cells were
plated at a density 5000 cells/well in 96-well plates (BD Biosciences, San Diego,
CA). Peptide was directly introduced to each well after 48 h of culture and then
incubated for an additional 48 h. For time dependent experiments, cells were
incubated with peptide for the specified time points. After the incubation period,
20 µL CTB reagent was added to each well and incubated at 37 °C and 5% CO2 for
2.5–3.5 h. Fluorescence of the resorufin product was measured on a FluoDia T70
fluorescence plate reader (Photon Technology International, Birmingham, NJ,
USA). All wells included the same amount of water to account for different con-
centrations of peptide added to sample wells. Wells that included water vehicle but
not peptide served as the negative control (0% toxic), and wells containing 10%
DMSO were the positive control (100% toxic). Percent toxicity was calculated using
the following equation:




Each independent variable is the average of eight plate replicates from the
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Fig. 10 IAPP oligomers on GPMVs are not amyloid. a Intermolecular FRETeff
statistics from 50 ROIs of aggregates prepared using IAPPA488, IAPPA647
and unlabelled IAPP (1:1:500). GPMV induced aggregates (orange) were
prepared under conditions of 10:1:0 IAPP:lipid:ADM-116 with images taken
60′ after exposure of 50 μM IAPP to 5 μM GPMV. These are overlaid with
FRETeff statistics of a control in which IAPP is in an amyloid conformation at
1:1:500 (Fig. 6a). Confocal imaging and FRETeff analysis was performed
using procedures identical to that used for the GPMVs. Vertical dotted red
lines correspond to specie positions defined in Fig. 8e. b, c Confocal
imaging of IAPP aggregates prepared from IAPP doped with IAPPA647
(500:1) and further stained with the amyloid indicator dye, ThT. Two
channel image pairs are shown for ThT (green) and IAPPA647 (blue),
respectively. Aggregates were prepared either in the presence of GPMVs
(b) or in buffer (c). Scale bar for all images is 5 μm. d Image statistics for
data as in b, c. Presented ThT intensities normalised to IAPPA647 intensities
using ROIs away from the GPMV surface. Error bars are standard
deviations from sets of experiments conducted on three independent
occasions
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presented for viability experiments are an average of three such experiments
conducted independently on different days. Error bars represent the standard error
of the mean.
Phosphate assay. Lipid concentrations for GPMV preparations were determined
by measuring total phosphate35, assuming that all measured phosphate is from
phospholipids, and that all lipids are phospholipids. This is a practical assumption
designed to ensure reproducibility.
Simulation of diluted-FRET. Expected values of FRETeff for dynamic, isotropic
distributions of spherically distributed IAPP were computed by numerical inte-
gration coded in-house using Mathematica (Wolfram Research, Champaign, IL).
Briefly, the experimental ratio of labelled to unlabelled protein defines a binomial
probability for the number of fluorophores distributed within trial spheres. The size
of the spheres was dictated by constants (stated in the main text) for protein
density and the total number of placed protein molecules. Spherical oligomers were
generated randomly until the cumulative FRETeff converged to a single value.
Occurrences of multiple acceptors and donors within a single oligomer were
accommodated by treating each potential dye pair, ij, as having an independent
probability of resonance transfer, pij. For example, a trial oligomer containing a
single donor and three acceptors located a distance of Ro away gives a FRETeff=
0.875. Effects of donor–donor and acceptor–acceptor interactions were not con-
sidered. In general, multi-fluorophore corrections contribute negligibly to com-
putations performed at the experimental ratios used in this work (Fig. 6c).
The fraction of oligomers of size N with one donor and one acceptor at a
doping ratio of 1:1:X is binomial with a probability of (2/(X+ 2)). This is further
scaled by 0.5 to reflect the frequency that the two labelled IAPPs within the
oligomer are donor and acceptor. Higher degrees of labelling within oligomers are
rare at the doping ratios used in this work and so are ignored. To calculate the
number of acceptor molecules contributing to the FRET signal detected, the
number of pixels showing FRET was divided by the total number of acceptor pixels
obtained from the acceptor channel.
Statistical analysis. For each experiment, means and standard deviations (spe-
cified in Figure Legends) of parameters measured were determined. Statistical
analyses were performed using the Student’s t-test and expressed as p-values in the
text. All analyses were carried out with GraphPad Prism.
Data availability. The data supporting the findings of this manuscript are available
from the corresponding authors upon reasonable request.
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